Omega Healthcare Investors Stock Last Dividend Paid
| OHI Stock | USD 40.00 0.21 0.53% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Omega Healthcare's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Omega Healthcare Investors Company Last Dividend Paid Analysis
Omega Healthcare's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Omega Healthcare Last Dividend Paid | 2.68 |
Most of Omega Healthcare's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omega Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Omega Healthcare Investors has a Last Dividend Paid of 2.68. This is much higher than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The last dividend paid for all United States stocks is notably lower than that of the firm.
Omega Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omega Healthcare's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omega Healthcare could also be used in its relative valuation, which is a method of valuing Omega Healthcare by comparing valuation metrics of similar companies.Omega Healthcare is currently under evaluation in last dividend paid category among its peers.
Omega Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0447 | ||||
| Profit Margin | 0.42 % | ||||
| Operating Margin | 0.64 % | ||||
| Current Valuation | 16.05 B | ||||
| Shares Outstanding | 295 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 72.18 % | ||||
| Number Of Shares Shorted | 9.68 M | ||||
| Price To Earning | 30.17 X | ||||
| Price To Book | 2.35 X | ||||
| Price To Sales | 10.82 X | ||||
| Revenue | 1.05 B | ||||
| Gross Profit | 1.11 B | ||||
| EBITDA | 947.11 M | ||||
| Net Income | 417.8 M | ||||
| Cash And Equivalents | 518.34 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 4.84 B | ||||
| Debt To Equity | 1.35 % | ||||
| Current Ratio | 2.57 X | ||||
| Book Value Per Share | 17.02 X | ||||
| Cash Flow From Operations | 749.43 M | ||||
| Short Ratio | 3.46 X | ||||
| Earnings Per Share | 1.62 X | ||||
| Price To Earnings To Growth | 1.13 X | ||||
| Target Price | 40.86 | ||||
| Number Of Employees | 60 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 12.06 B | ||||
| Total Asset | 9.9 B | ||||
| Retained Earnings | (3.43 B) | ||||
| Working Capital | 2.31 B | ||||
| Current Asset | 223.89 M | ||||
| Current Liabilities | 15.35 M | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 8.16 % | ||||
| Net Asset | 9.9 B | ||||
| Last Dividend Paid | 2.68 |
About Omega Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omega Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omega Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omega Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Omega Healthcare Piotroski F Score and Omega Healthcare Altman Z Score analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Trading space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.